This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hu, B.
Right arrow Articles by Blanchard, K. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hu, B.
Right arrow Articles by Blanchard, K. L.

 Previous Article  |  Next Article 

Mol. Cell. Biol., Feb 1997, 851-856, Vol 17, No. 2
Copyright © 1997, American Society for Microbiology

In vivo analysis of DNA-protein interactions on the human erythropoietin enhancer

B Hu, E Wright, L Campbell and KL Blanchard
Center for Excellence in Cancer Research, Treatment and Education, Louisiana State University Medical Center, Shreveport 71130, USA.

The erythropoietin (EPO) gene is one of the best examples of a mammalian gene controlled by oxygen tension. The DNA elements responsible for hypoxia-induced transcription consist of a short region of the proximal promoter and a <50-bp 3' enhancer. The elements act cooperatively to increase the transcriptional initiation rate approximately 100-fold in response to low oxygen tension in Hep3B cells. Two distinct types of transactivating proteins have been demonstrated to bind the response elements in the human EPO enhancer in vitro: one shows hypoxia-inducible DNA binding activity, while the other activity binds DNA under normoxic and hypoxic conditions. We have investigated the DNA-protein interactions on the human EPO enhancer in living tissue culture cells that produce EPO in a regulated fashion (Hep3B) and in cells that do not express EPO under any conditions tested (HeLa). We have identified in vivo DNA-protein interactions on the control elements in the human EPO enhancer by ligation-mediated PCR technology. We show that the putative protein binding sites in the EPO enhancer are occupied in vivo under conditions of normoxia, hypoxia, and cobalt exposure in EPO-producing cells. These sites are not occupied in cells that do not produce EPO. We also provide evidence for a conformational change in the topography of the EPO enhancer in response to hypoxia and cobalt exposure.


This article has been cited by other articles:

  • Breit, J. F., Ault-Ziel, K., Al-Mehdi, A.-B., Gillespie, M. N. (2008). Nuclear protein-induced bending and flexing of the hypoxic response element of the rat vascular endothelial growth factor promoter. FASEB J. 22: 19-29 [Abstract] [Full Text]  
  • Mense, S. M., Sengupta, A., Zhou, M., Lan, C., Bentsman, G., Volsky, D. J., Zhang, L. (2006). Gene expression profiling reveals the profound upregulation of hypoxia-responsive genes in primary human astrocytes. Physiol. Genomics 25: 435-449 [Abstract] [Full Text]  
  • Wenger, R. H., Stiehl, D. P., Camenisch, G. (2005). Integration of Oxygen Signaling at the Consensus HRE. Sci Signal 2005: re12-re12 [Abstract] [Full Text]  
  • Kovtun, I.V., Thornhill, A.R., McMurray, C.T. (2004). Somatic deletion events occur during early embryonic development and modify the extent of CAG expansion in subsequent generations. Hum Mol Genet 13: 3057-3068 [Abstract] [Full Text]  
  • Lavista-Llanos, S., Centanin, L., Irisarri, M., Russo, D. M., Gleadle, J. M., Bocca, S. N., Muzzopappa, M., Ratcliffe, P. J., Wappner, P. (2002). Control of the Hypoxic Response in Drosophila melanogaster by the Basic Helix-Loop-Helix PAS Protein Similar. Mol. Cell. Biol. 22: 6842-6853 [Abstract] [Full Text]  
  • WENGER, R. H. (2002). Cellular adaptation to hypoxia: O2-sensing protein hydroxylases, hypoxia-inducible transcription factors, and O2-regulated gene expression. FASEB J. 16: 1151-1162 [Abstract] [Full Text]  
  • Kambe, T., Tada-Kambe, J., Kuge, Y., Yamaguchi-Iwai, Y., Nagao, M., Sasaki, R. (2000). Retinoic acid stimulates erythropoietin gene transcription in embryonal carcinoma cells through the direct repeat of a steroid/thyroid hormone receptor response element half-site in the hypoxia-response enhancer. Blood 96: 3265-3271 [Abstract] [Full Text]  
  • Wenger, R. (2000). Mammalian oxygen sensing, signalling and gene regulation. J. Exp. Biol. 203: 1253-1263 [Abstract]  
  • Yin, H., Blanchard, K. L. (2000). DNA methylation represses the expression of the human erythropoietin gene by two different mechanisms. Blood 95: 111-119 [Abstract] [Full Text]  
  • Ebert, B. L., Bunn, H. F. (1999). Regulation of the Erythropoietin Gene. Blood 94: 1864-1877 [Full Text]  
  • Zhang, L., Spratt, S. K., Liu, Q., Johnstone, B., Qi, H., Raschke, E. E., Jamieson, A. C., Rebar, E. J., Wolffe, A. P., Case, C. C. (2000). Synthetic Zinc Finger Transcription Factor Action at an Endogenous Chromosomal Site. ACTIVATION OF THE HUMAN ERYTHROPOIETIN GENE. J. Biol. Chem. 275: 33850-33860 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»